These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14979908)

  • 81. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling.
    Brisken C; Heineman A; Chavarria T; Elenbaas B; Tan J; Dey SK; McMahon JA; McMahon AP; Weinberg RA
    Genes Dev; 2000 Mar; 14(6):650-4. PubMed ID: 10733525
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.
    Li Y; Hively WP; Varmus HE
    Oncogene; 2000 Feb; 19(8):1002-9. PubMed ID: 10713683
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The hallmarks of cancer.
    Hanahan D; Weinberg RA
    Cell; 2000 Jan; 100(1):57-70. PubMed ID: 10647931
    [No Abstract]   [Full Text] [Related]  

  • 84. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.
    Prenzel N; Zwick E; Daub H; Leserer M; Abraham R; Wallasch C; Ullrich A
    Nature; 1999 Dec 23-30; 402(6764):884-8. PubMed ID: 10622253
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint.
    Lukas J; Bartkova J; Bartek J
    Mol Cell Biol; 1996 Dec; 16(12):6917-25. PubMed ID: 8943347
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
    Beerli RR; Hynes NE
    J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
    Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differential transformation of mammary epithelial cells by Wnt genes.
    Wong GT; Gavin BJ; McMahon AP
    Mol Cell Biol; 1994 Sep; 14(9):6278-86. PubMed ID: 8065359
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.
    Nusse R; Varmus HE
    Cell; 1982 Nov; 31(1):99-109. PubMed ID: 6297757
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor.
    Coleman S; Silberstein GB; Daniel CW
    Dev Biol; 1988 Jun; 127(2):304-15. PubMed ID: 3259938
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain.
    Roelink H; Wagenaar E; Lopes da Silva S; Nusse R
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4519-23. PubMed ID: 2162045
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
    Edwards PA; Hiby SE; Papkoff J; Bradbury JM
    Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
    Musgrove EA
    Breast Cancer Res; 2004; 6(2):65-8. PubMed ID: 14979908
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
    Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
    Massarweh S; Schiff R
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Three-dimensional extracellular matrix culture models of EGFR signalling and drug response.
    Kenny PA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):665-8. PubMed ID: 17635116
    [TBL] [Abstract][Full Text] [Related]  

  • 98. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization.
    Lo HW; Hsu SC; Hung MC
    Breast Cancer Res Treat; 2006 Feb; 95(3):211-8. PubMed ID: 16261406
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.
    Astsaturov I; Cohen RB; Harari P
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1179-93. PubMed ID: 17020453
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Autocrine, paracrine and juxtacrine signaling by EGFR ligands.
    Singh AB; Harris RC
    Cell Signal; 2005 Oct; 17(10):1183-93. PubMed ID: 15982853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.